{"pmid":32221526,"title":"COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.","text":["COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.","J Crohns Colitis","Bai, Xiaoyin","Yang, Hong","Qian, Jiaming","32221526"],"journal":"J Crohns Colitis","authors":["Bai, Xiaoyin","Yang, Hong","Qian, Jiaming"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221526","week":"202014|Mar 30 - Apr 05","doi":"10.1093/ecco-jcc/jjaa064","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662624089096847360,"score":7.2532344,"similar":[{"pmid":32211765,"title":"Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.","text":["Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.","The outbreak of the COVID-19 caused by Coronavirus SARS-CoV2, is rapidly spreading worldwide. This is the first pandemic caused by a Coronavirus in history. More than 150,000 confirmed cases worldwide are reported by the SARS-CoV2, with more than 5,000 COVID-19-related deaths on March 14th, 2020. Fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhoea, confusion, dyspnoea, and bilateral interstitial pneumonia are the common symptoms. No therapies are available, and the only way to contain the virus spread is to regularly and thoroughly clean oneself hands with an alcohol-based hand rub or wash them with soap and water, to maintain at least 1 metre (3 feet) distance from anyone who is coughing or sneezing, to avoid touching eyes, nose and mouth, and to stay home if one feels unwell. No data are available on the risk of COVID-19 and outcomes in inflammatory bowel disease (IBD) patients. Outbreak restrictions can impact on the IBD care. We aim to give a viewpoint on how operationally manage IBD patients ensuring quality of care in the current pandemic era.","J Crohns Colitis","Fiorino, Gionata","Allocca, Mariangela","Furfaro, Federica","Gilardi, Daniela","Zilli, Alessandra","Radice, Simona","Spinelli, Antonino","Danese, Silvio","32211765"],"abstract":["The outbreak of the COVID-19 caused by Coronavirus SARS-CoV2, is rapidly spreading worldwide. This is the first pandemic caused by a Coronavirus in history. More than 150,000 confirmed cases worldwide are reported by the SARS-CoV2, with more than 5,000 COVID-19-related deaths on March 14th, 2020. Fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhoea, confusion, dyspnoea, and bilateral interstitial pneumonia are the common symptoms. No therapies are available, and the only way to contain the virus spread is to regularly and thoroughly clean oneself hands with an alcohol-based hand rub or wash them with soap and water, to maintain at least 1 metre (3 feet) distance from anyone who is coughing or sneezing, to avoid touching eyes, nose and mouth, and to stay home if one feels unwell. No data are available on the risk of COVID-19 and outcomes in inflammatory bowel disease (IBD) patients. Outbreak restrictions can impact on the IBD care. We aim to give a viewpoint on how operationally manage IBD patients ensuring quality of care in the current pandemic era."],"journal":"J Crohns Colitis","authors":["Fiorino, Gionata","Allocca, Mariangela","Furfaro, Federica","Gilardi, Daniela","Zilli, Alessandra","Radice, Simona","Spinelli, Antonino","Danese, Silvio"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32211765","week":"202013|Mar 23 - Mar 29","doi":"10.1093/ecco-jcc/jjaa058","keywords":["COVID-19","Coronavirus","inflammatory bowel disease","pandemic","quality of care"],"source":"PubMed","locations":["Humanitas","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1662444220138389504,"score":59.0823},{"pmid":32215548,"title":"Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?","text":["Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?","Crohn's disease (CD)] and ulcerative colitis (UC), the main inflammatory bowel diseases (IBD) in human beings, are chronic, immune-inflammatory diseases, whose pathogenesis implicates a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant nowadays, as coronavirus disease (Covid-19) has rapidly spread from China to countries where IBD are more prevalent and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the cells and to illustrate the link between such determinants and the intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk to be infected with SARS-CoV-2 and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia.","J Crohns Colitis","Monteleone, Giovanni","Ardizzone, Sandro","32215548"],"abstract":["Crohn's disease (CD)] and ulcerative colitis (UC), the main inflammatory bowel diseases (IBD) in human beings, are chronic, immune-inflammatory diseases, whose pathogenesis implicates a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant nowadays, as coronavirus disease (Covid-19) has rapidly spread from China to countries where IBD are more prevalent and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the cells and to illustrate the link between such determinants and the intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk to be infected with SARS-CoV-2 and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia."],"journal":"J Crohns Colitis","authors":["Monteleone, Giovanni","Ardizzone, Sandro"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215548","week":"202013|Mar 23 - Mar 29","doi":"10.1093/ecco-jcc/jjaa061","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1662445896441266176,"score":57.717026},{"pmid":32220656,"title":"Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.","text":["Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.","Lancet Gastroenterol Hepatol","Zingone, Fabiana","Savarino, Edoardo Vincenzo","32220656"],"journal":"Lancet Gastroenterol Hepatol","authors":["Zingone, Fabiana","Savarino, Edoardo Vincenzo"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220656","week":"202014|Mar 30 - Apr 05","doi":"10.1016/S2468-1253(20)30085-6","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1662624089091604481,"score":56.669403},{"pmid":32220077,"title":"A survey of 434 clinical trials about coronavirus disease 2019 in China.","text":["A survey of 434 clinical trials about coronavirus disease 2019 in China.","J Med Virol","Leng, Zikuan","Yin, Dongfei","Zhao, Zhe","Yan, Miaoheng","Yang, Yanlei","He, Xijing","Zhao, Robert Chunhua","Liu, Hongjian","32220077"],"journal":"J Med Virol","authors":["Leng, Zikuan","Yin, Dongfei","Zhao, Zhe","Yan, Miaoheng","Yang, Yanlei","He, Xijing","Zhao, Robert Chunhua","Liu, Hongjian"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220077","week":"202013|Mar 23 - Mar 29","doi":"10.1002/jmv.25779","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1662540582087557120,"score":54.803608},{"pmid":32114755,"title":"A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey.","text":["A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey.","Controversy remains over whether the novel coronavirus 2019 (COVID-19) virus may have infectivity during the incubation period before the onset of symptoms. The author had the opportunity to examine the infectivity of COVID-19 during the incubation period by conducting an epidemiological survey on a confirmed patient who had visited Jeju Island during the incubation period. The epidemiological findings support the claim that the COVID-19 virus does not have infectivity during the incubation period.","J Prev Med Public Health","Bae, Jong-Myon","32114755"],"abstract":["Controversy remains over whether the novel coronavirus 2019 (COVID-19) virus may have infectivity during the incubation period before the onset of symptoms. The author had the opportunity to examine the infectivity of COVID-19 during the incubation period by conducting an epidemiological survey on a confirmed patient who had visited Jeju Island during the incubation period. The epidemiological findings support the claim that the COVID-19 virus does not have infectivity during the incubation period."],"journal":"J Prev Med Public Health","authors":["Bae, Jong-Myon"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32114755","week":"202010|Mar 02 - Mar 08","doi":"10.3961/jpmph.20.048","keywords":["Coronavirus","Infectious disease incubation period","COVID-19"],"source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1662334544111468545,"score":49.127563}]}